Sandeep Gurbuxani MD, PhD

Contact

Clinical Interests


Hematopathology

Research Interests


I am interested in mechanisms of resistance to chemotherapy induce cell death in cancer. The focus of my current research is the mechanism of glucocorticoid induced cell death (and the resistance to this cell death) in acute lymphoblastic leukemia (ALL).

While significant progress has been made in the therapy of childhood ALL, the outcome for adult ALL and relapsed ALL remains poor.
Glucocorticoids (GCs) such as dexamethasone and prednisone are the mainstay of ALL therapy. Multiple studies in childhood ALL have demonstrated GC resistance measured in vitro as well as in vivo after GC monotherapy to be the single most important predictor of response to therapy in childhood ALL. In spite of the crucial role of GCs in ALL therapy, the mechanisms of cell death induced upon GC exposure are poorly understood. Understanding the pathway(s) involved in GC mediated cell death is a crucial first step in understanding the mechanisms of GC resistance in ALL.

I am also interested in the process of hematopoiesis - specifically the pro survival signals required during hematopoietic differentiation.
Additional interests include the biology of myeloproliferative neoplasms.

Hematopathology

Publications

  • Gurbuxani S, Anastasi J. What to Do When You Suspect Gastrointestinal Lymphoma: A Pathologist's
    Perspective. Clin Gastroenterol Hepatol. 2007 Mar 1; [Epub ahead of print]
  • Gurbuxani S. CD36 - a marker for drug sensitive acute megakaryoblastic leukemia. Leuk Lymphoma. 2006 Oct;47(10):2004-5.
  • Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD. Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11480-5.
  • Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, Droin N, Hamai A, Pequignot M, Hammann A, Moutet M, Fromentin A, Kroemer G, Solary E, Garrido C.  Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C. Cancer Res. 2004 Apr 15;64(8):2705-11.
  • Schmitt E, Parcellier A, Gurbuxani S, Cande C, Hammann A, Morales MC, Hunt CR, Dix DJ, Kroemer RT, Giordanetto F, Jaattela M, Penninger JM, Pance A, Kroemer G, Garrido C. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res. 2003 Dec 1;63(23):8233-40.